- Category
- Small (2021-22)
- Udyam number
- UDYAM-HP-11-0004972

About Maya Biotech Private Limited
Data last updated:
Maya Biotech Private Limited is a private limited company based in Chandigarh, India, a subsidiary of Mediaid Labs Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 May 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U55101CH1998PTC021391. Its GSTIN is 04AABCD3307M1ZX (Chandigarh).
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹1.18 Cr. It was formerly known as Toshika Laboratories Private Limited and Drs Hotels Private Limited. It is led by directors Manoj Agarwal (Whole-Time Director) and Parth Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No. 46 Ram Darbar Industrial Area Phase – 2, Chandigarh, India – 160002.
As per the financials filed for FY 2024, the company reported a revenue of ₹42.5 Cr, a decline of 3% compared to the previous year. For the same year it recorded a net profit of ₹3.77 Cr (net margin 8.9%) and EBITDA of ₹7.72 Cr (EBITDA margin 18.2%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 17% over five years.
The company has about 49 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹3.3 Cr and satisfied charges of ₹1.7 Cr on record. Court records list 9 cases involving the company, including 4 filed by the company and 5 filed against it; 2 cases are pending. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.16 Cr; the latest was in March 2013. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Legency Remedies Private Limited with revenue of ₹42.77 Cr.
Maya Biotech Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0004972). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mayabiotechindia.com.
Company details
Name history
Maya Biotech has undergone 2 name changes throughout its history. The company was previously known as Toshika Laboratories Private Limited, and Drs Hotels Private Limited. The current legal name is Maya Biotech Private Limited.
| Company Name | Status |
|---|---|
| Maya Biotech Private Limited | Current |
| Toshika Laboratories Private Limited | Previous |
| Drs Hotels Private Limited | Previous |
Recognitions & Rankings of Maya Biotech
Contact details
Maya Biotech Private Limited's registered office is in Chandigarh, Chandigarh. Its website is mayabiotechindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 46 Ram Darbar Industrial Area Phase – 2, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maya Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Maya Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Maya Biotech Private Limited, buy the company report.
Financials of Maya Biotech Private Limited
FY 2024 filings availableMaya Biotech Private Limited reported revenue of ₹42.5 Cr (down 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 3% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹42.5 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.72 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.77 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.2% | ||||
| Net Profit Margin | 8.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maya Biotech Private Limited, buy the company report.
Board of directors of Maya Biotech Private Limited
Maya Biotech has 2 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manoj Agarwal Also directs: Rudraksha Entertainment LLP, Mediaid Labs LLP, Carelife Foods Private Limited and 2 more | Whole-Time Director | 14 May 2012 | 14 Years 6 Months | Current |
| Parth Agarwal | Director | 10 Oct 2019 | 7 Years 1 Months | Current |
Peer comparison
Maya Biotech Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Legency Remedies Private Limited | ₹42.77 Cr (FY 2025) | -11.0% | Baddi, Himachal Pradesh, India | |||
| Brussels Laboratories Pvt Ltd | ₹42.73 Cr (FY 2025) | 7.0% | Dist-Ahmedabad, Gujarat, India | |||
| La Chemico Pvt Ltd | ₹42.52 Cr (FY 2024) | 0.0% | Kolkata, West Bengal, India | |||
| Maya Biotech Private Limitedthis company | ₹42.5 Cr (FY 2024) | ₹3.77 Cr | 8.9% | -3.0% | 49 | Chandigarh, India |
| Base Medico Private Limited | ₹42.21 Cr (FY 2025) | -12.0% | Vadodara, Gujarat, India | |||
| Spectrum Formulation Private Limited | ₹42.18 Cr (FY 2025) | 23.0% | Indore, Madhya Pradesh, India | |||
| Supercure Biotech Private Limited | ₹42.03 Cr (FY 2024) | 6.0% | Delhi, India | |||
| International Ingredients & Excipients Private Limited | ₹41.96 Cr (FY 2025) | 58.0% | Chennai, Tamil Nadu, India | |||
| Samrudh Pharmacare Private Limited | ₹41.88 Cr (FY 2024) | -7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Maya Biotech Private Limited, buy the company report.
Auditor
Maya Biotech Private Limited is audited by VIJAYANT GOYAL & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIJAYANT GOYAL & ASSOCIATES | FY 2024 | 021943N |
Shareholding
The shareholding of Maya Biotech Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maya Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Aug 2024 | 100977945 | Others | ₹50 Lakh | Open | |
| 16 Feb 2013 | 10411862 | Axis Bank Limited | ₹1.9 Cr | Open | |
| 02 Feb 2013 | 10408383 | Axis Bank Limited | ₹55 Lakh | Open | |
| 02 Feb 2013 | 10409688 | Axis Bank Limited | ₹35 Lakh | Open | |
| 30 May 2011 | 10288039 | Uco Bank | ₹1 Cr | Satisfied |
To see the full charge records of Maya Biotech Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Maya Biotech Private Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.16 Cr; the latest was in March 2013.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: Mediaid Labs Private Limited Seller: 4 individuals |
| May 2012 | Funding round | ₹86.9 Lakh | Investors: Mediaid Labs Private Limited , 3 individuals |
| May 2012 | Funding round | ₹16.3 Lakh | Investors: Mediaid Labs Private Limited |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Devenderjit Singh Dhillon Huf, 3 individuals |
| Jun 2007 | Funding round | ₹13.2 Lakh | Investors: Devenderjit Singh Dhillon Huf, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Maya Biotech Private Limited has 9 court cases on record: 4 filed by Maya Biotech, 5 filed against it. 2 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 5 | 2 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Court case (Regular Suit misc) | Filed against the company by Organophillic Technologies Pvt Ltd | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ms Serene Bioscience Pvt Ltd | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ms Coterie Marketing Pvt Ltd | Disposed |
| District court, Solan, Himachal Pradesh | Court case (Drugs And Cosmetics Act) | Filed against the company by Union of India Through Drugs Inspector | Pending |
| District court, BELAGAVI, Karnataka | Criminal miscellaneous application | Filed against the company by State at the Instance of Drugs Inspctor-03,R/Othe Regional Dputy Drugs Cntrollr,Cts No.1848,Bgv | Disposed |
To see the full case history of Maya Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maya Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Maya Biotech Private Limited has a workforce of 49 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 49 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Maya Biotech Private Limited, buy the company report.
GST
Maya Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AABCD3307M1ZX | Chandigarh | Active | 05 Sep 2021 |
To see the full GST registrations and return filing status of Maya Biotech Private Limited, buy the company report.
Recent activity
Maya Biotech Private Limited has 23 board changes on record since 2011: 2 appointments and 21 cessations. The latest: Parth Agarwal ceased to be Additional Director on 31 Dec 2020.
25 earlier events are in the company report.
Frequently asked questions
Maya Biotech is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 May 1998 (28+ years old) and is registered under CIN U55101CH1998PTC021391.
Maya Biotech has 2 current directors:
- Manoj Agarwal - Whole-Time Director
- Parth Agarwal - Director
The latest financial statements of Maya Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Maya Biotech is 04AABCD3307M1ZX, registered in Chandigarh.
The CIN (Corporate Identification Number) of Maya Biotech is U55101CH1998PTC021391. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maya Biotech has 9 court cases on record: 4 filed by the company and 5 filed against it. 2 are pending.
Maya Biotech was incorporated on 15 May 1998, making it 28+ years old. It is registered with the Registrar of Companies, Chandigarh.
Maya Biotech has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.16 Cr; the latest was in March 2013.
The peers of Maya Biotech by revenue are Legency Remedies Private Limited, Brussels Laboratories Pvt Ltd, La Chemico Pvt Ltd, Base Medico Private Limited, Spectrum Formulation Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Parth Agarwal ceased to be Additional Director on 31 Dec 2020. Parth Agarwal was appointed as Director on 10 Oct 2019. Janki Ballabh Agarwal ceased to be Additional Director on 30 Sep 2019. Maya Biotech has 23 board changes on record in total.
Yes, Maya Biotech is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0004972).

